We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Ultrapotent Bispecific Antibodies That Can Simultaneously Bind to Two Different Antigens Neutralize SARS-CoV-2 Variants

By HospiMedica International staff writers
Posted on 15 Sep 2021
Print article
Researchers have developed bispecific antibodies - antibodies that can simultaneously bind to two different antigens - that target multiple regions of the SARS-CoV-2 spike protein and neutralize virus variants of concern.

The team of researchers from the National Institute of Allergy and Infectious Diseases (NIAID; Bethesda, MD, USA) isolated monoclonal antibodies targeting the SARS-CoV-2 spike protein from donors who had recovered from COVID-19. Pairs of potent monoclonal antibodies that bound distinct regions of the spike protein were combined into bispecific antibodies. These bispecific antibodies prevented SARS-CoV-2 variants of concern from infecting cells in vitro and prevented disease in hamsters infected with SARS-CoV-2.

Currently, COVID-19 antibody treatments work by sending in a cocktail of individual monoclonal antibodies to target various parts of the virus. However, the NIAID researchers showed that combining some of these monoclonal antibodies into a new bispecific antibody can create stronger antibodies that are more potent than the monoclonal cocktails - one bispecific antibody they tested, in particular, was 100 times more potent against the virus than a cocktail of its monoclonal parents.

Two of the bispecific antibodies neutralized the original virus as well as the Alpha, Beta, Gamma, and Delta variants. In hamsters infected with SARS-CoV-2, two of the bispecific antibodies protected the animals from clinical disease. The researchers developed the bispecific antibodies from a pool of 216 monoclonal antibodies that target SARS-CoV-2 from convalescent COVID-19 patients, screening them for potency against the virus. The bispecific antibodies may be especially effective against the variants because they bind to non-overlapping areas of the viral spike and have limited contact with areas on the spike where variant mutations have occurred.

“In the face of rapidly emerging SARS-CoV-2 variants that challenge our efforts to end the pandemic, our findings support the further exploration of bispecific antibodies that strategically combine antibody pairs as new tools to treat COVID-19,” stated Hyeseon Cho from the team of NIAID researchers.

Related Links:

Print article


Critical Care

view channel
Image: Sponge electrodes in a variety of thicknesses (Photo courtesy of ACS Nano 2022)

Low-Cost Sponge Electrodes Improve Signal Detection for Medical Monitoring

To monitor heart rhythms and muscle function, doctors often attach electrodes to a patient’s skin, detecting the electrical signals that lie beneath. These impulses are vital to the early diagnosis and... Read more

Surgical Techniques

view channel
Image: MTS101 monitor meets increasing demand for location flexibility in the OR (Photo courtesy of MediCapture)

USB Powered Multi-Touch Monitor Allows Control of Surgical Sessions from Anywhere in the OR

A medical video recording system combined with a medical-grade multi-touch monitor offers direct network and Wi-Fi connections to PACS with the ability to control surgical sessions from anywhere in the... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more


view channel
Image: The global capsule endoscopy system market is growing at a rapid pace (Photo courtesy of Pexels)

Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure

Capsule endoscopy is generally a non-invasive technique that enables complete examination of the gastrointestinal tract with the use of the disposable and wireless device known as the video capsule.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.